Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease hepatitis c
Symptom |cirrhosis
Sentences 141
PubMedID- 21360032 The average recoveries +/- rsd for the healthy subjects, cirrhosis of chronic hepatitis c and b, and hcc serum samples were 102.6 +/- 1.01%, 101.5 +/- 0.95%, and 100.1 +/- 1.1%, respectively.
PubMedID- 20426802 Once developed, 30% to 40% of these patients succumb a liver-related death over a 10-year period , a mortality rate similar to or worse than cirrhosis associated with hepatitis c. nash-associated cirrhosis can also develop into into a subacute liver failure, or progress to hepatocellular cancer , as well as reoccur after liver transplantation.
PubMedID- 23139898 In fact, the proportion of chronic hepatitis c patients with cirrhosis is expected to reach 25% in 2010 and 45% in 2030 (davis et al.
PubMedID- 21182362 Chronic hepatitis c is associated with cirrhosis, hepatic failure, and death; therefore, treatment is aimed at reducing these complications, as well as improving quality of life and minimizing adverse effects.
PubMedID- 20217081 Hepatocellular carcinoma (hcc) occurs most commonly secondary to cirrhosis due to chronic hepatitis c or b virus (hcv/hbv) infections.
PubMedID- 21335180 The etiology that led to our first transplantation was cirrhosis due to hepatitis c virus (hcv; n = 6), followed by acute liver failure, (n = 5).
PubMedID- 24919730 A patient with local recurrence of hepatocellular carcinoma 36 months after liver transplant for multifocal hepatocellular carcinoma and cirrhosis due to hepatitis c was successfully treated with laparoscopic microwave ablation without any postoperative complications.
PubMedID- 21221473 Conclusion: patients with cirrhosis due to hepatitis c virus who achieved sustained virological response had significantly lower incidence of hepatocellular carcinoma when compared to those without treatment response.
PubMedID- 24603710 Most patients had liver cirrhosis (90%); mainly due to chronic hepatitis c infection; and 40% had ascites.
PubMedID- 21920398 Kir genes and their human leukocyte antigen ligands in the progression to cirrhosis in patients with chronic hepatitis c.
PubMedID- 25228702 Complications of cirrhosis due to hepatitis c virus (hcv) are increasing, and liver transplantation (lt) is the most effective treatment for those with liver decompensation or small hepatocellular carcinoma.
PubMedID- 24824121 Life quality analysis of hepatitis c patients with liver cirrhosis undergoing antiviral therapy following splenectomy.
PubMedID- 20970581 The diagnosis was graft cirrhosis due to hepatitis c virus in 2 of them, who were already included on waiting lists for retransplantation, and the third, unknown alcoholic cirrhosis.
PubMedID- 25374720 In this paper, we report on a 48-year-old patient with pleuropulmonary nocardiosis and cirrhosis due to chronic hepatitis c virus infection treated with triple antiviral treatment complicated by prolonged neutropenia.
PubMedID- 25398070 cirrhosis in hepatitis c virus-infected patients: a review for practitioners new to hepatitis c care.
PubMedID- 22368686 Several noninvasive direct and indirect serum markers (such as fibrotest®, fibrometer®, and hepascore®) have been developed and proposed for the noninvasive prediction of significant fibrosis and cirrhosis, especially in patients with chronic hepatitis c 1.
PubMedID- 20964825 Tlr4 was identified as one of seven genes associated with increased risk of developing cirrhosis in patients with chronic hepatitis c .
PubMedID- 24575405 cirrhosis due to hepatitis c virus (hcv) is becoming the main indication for liver transplantation (lt).
PubMedID- 21889468 Conclusions: a method without the use of a gold standard confirmed the accuracy of fibrotest and fibroscan for the diagnosis of advanced fibrosis and cirrhosis in patients with chronic hepatitis c.
PubMedID- 24781929 Orthotopic liver transplantation for liver cirrhosis due to hepatitis c virus in patients with hemophilia a: two benefits of one procedure.
PubMedID- 20497143 Systematic review: outcome of compensated cirrhosis due to chronic hepatitis c infection.
PubMedID- 21687605 However, these results have been challenged by a few recent studies that have demonstrated reasonable differentiation between stages of cirrhosis in patients with mostly hepatitis c-related liver disease .
PubMedID- 25331666 Chronic hepatitis c (chc) frequently leads to cirrhosis with an increased risk of hepatocellular carcinomas (hcc).
PubMedID- 22916613 The main indications for liver transplantation in adults were: cirrhosis due to chronic hepatitis c in 47.5% and cirrhosis due to alcohol abuse in 15% of the group.
PubMedID- 22734241 Conclusion: the use of 135 microg peg-ifnalpha-2a and individual in low-dose ribavirin hepatitis c patients with cirrhosis is more security,could get a good early response, but sustained virologic response (svr) rates is lower than hepatitis c patients.
PubMedID- 26486859 Impact of liver cirrhosis due to chronic hepatitis c viral infection on the outcome of ovarian cancer: a prospective study.
PubMedID- 26215529 We estimated the prevalence of cirrhosis in adults with chronic hepatitis c (chc) using multiple parameters including liver biopsy, diagnosis/procedure codes, and a biomarker.
PubMedID- 21410221 Using this approach we show that the beta chains of complement c3 and c4 decrease in serum from hepatitis c patients with cirrhosis, a change not observed previously by 2-de.
PubMedID- 24693307 Several studies have investigated the potential usefulness of serum biomarkers of liver function and indices derived from these biomarkers in prediction of liver fibrosis and cirrhosis in patients with hepatitis c and b (7, 17, 19, 24).
PubMedID- 21253791 Curing hepatitis c infection in patients with cirrhosis through treatment with peginterferon and ribavirin reduces the risk of developing hepatocellular carcinoma.
PubMedID- 25764673 Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis c virus infection for the fiscal year 2014 in japan.
PubMedID- 21861016 Cryptococcal meningitis in hiv-negative patient with liver cirrhosis due to hepatitis c.
PubMedID- 23849467 The present cross-sectional study investigated 12 perfluoroalkyl substances (pfass) in serum (n=79) and liver (n=66) samples from patients who had undergone liver transplantation for a range of conditions, such as hepatocellular carcinoma (hcc), cirrhosis due to chronic hepatitis c viral infection (hcv), both hcc and hcv, amyloidosis or acute liver failure.
PubMedID- 23300494 Patients and methods: ninety patients were enrolled: 30 cases of chronic hepatitis c (chc) without cirrhosis, 30 cases of chc with liver cirrhosis, and 30 cases of hcc and hepatitis v virus (hcv) infection.
PubMedID- 22087173 cirrhosis due to chronic hepatitis c virus (hcv) infection is one of the leading indications for liver transplantation (lt) worldwide.
PubMedID- 24524410 Previously reported that serum levels of the aim protein were elevated in hepatitis c patients with liver cirrhosis compared to healthy controls, using a proteomics method based on 2-dimensional gel electrophoresis (2-de).
PubMedID- 22900194 The development of decompensated cirrhosis due to recurrent hepatitis c is now the most frequent cause of graft failure, patient death, and the need for retransplantation in hcv-infected recipients .
PubMedID- 24292581 Background/aim: a low platelet count is one of the most sensitive tests for cirrhosis detection in patients with hepatitis c virus (hcv) infection.
PubMedID- 24764777 There is a decreased rate of decompensated cirrhosis in women with hepatitis c virus infection, no survival difference in alcohol-related liver disease, and improved survival from hepatocellular carcinoma.
PubMedID- 25270208 Conclusion: from the stage of chronic infection to decompensated cirrhosis, patients with hepatitis c were found with the decreased numbers of cd4(+)t, cd8(+) t and nk lymphocytes, and the increased proportion of b lymphocyte and cd4/cd8 ratio.
PubMedID- 24008390 The leading cause of hepatic fibrosis and cirrhosis is infection with hepatitis c virus (hcv), and of the patients with hcv-induced cirrhosis, 2% to 5% develop hepatocellular carcinoma (hcc), with a survival rate of 7%.
PubMedID- 24731162 Background and aim: thrombocytopenia (tcp) of chronic hepatitis c patients with cirrhosis has a negative impact on the management of interferon-based treatment.
PubMedID- 25013622 Furthermore, hbv can induce hcc in the absence of cirrhosis, while patients with chronic hepatitis c almost always develop hcc in the presence of cirrhosis .
PubMedID- 21324927 A 52-yr-old man with uncompensated cirrhosis due to hepatitis c received an ldlt from his healthy daughter.
PubMedID- 25103219 Background: the hepatitis c virus may lead to cirrhosis, liver cancer, liver transplant, and increased mortality.
PubMedID- 25057737 From 1996 to 2006, the prevalence of cirrhosis among veterans with chronic hepatitis c infection rose from 9 to 18.5%, and the prevalence of hcc rose from 0.07 to 1.3%.
PubMedID- 21954650 Infection with the hepatitis c virus (hcv) leading to cirrhosis is the most common factor in the development of hcc.
PubMedID- 24308724 Von willebrand factor as a new marker for non-invasive assessment of liver fibrosis and cirrhosis in patients with chronic hepatitis c.
PubMedID- 24564861 For the cirrhosis group, patients with hepatitis c and biopsy proven cirrhosis were enrolled.
PubMedID- 21752038 Background: transient elastography measures liver stiffness, which correlates with the hepatic fibrosis stage and has excellent accuracy for the diagnosis of cirrhosis in patients with chronic hepatitis c.

Page: 1 2 3